Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1681 AL 1695

The "mitochondrial stress responses": the "Dr. Jekyll and Mr. Hyde" of neuronal disorders

Patergnani S, Morciano G, Carinci M, Leo S, Pinton P, Rimessi A.

Neural Regen Res. 2022 Dec;17(12):2563-2575. doi: 10.4103/1673-5374.339473.

From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer's and Parkinson's diseases

Wakhloo D, Oberhauser J, Madira A, Mahajani S.

Neural Regen Res. 2022 Dec;17(12):2606-2614. doi: 10.4103/1673-5374.336138.

Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases

Wang Q, Song LJ, Ding ZB, Chai Z, Yu JZ, Xiao BG, Ma CG.

Neural Regen Res. 2022 Dec;17(12):2623-2631. doi: 10.4103/1673-5374.335827.

Endogenous versus exogenous cell replacement for Parkinson's disease: where are we at and where are we going?

Mourtzi T, Kazanis I.

Neural Regen Res. 2022 Dec;17(12):2637-2642. doi: 10.4103/1673-5374.336137.

Astrocytic Calcium and cAMP in Neurodegenerative Diseases

Sobolczyk M, Boczek T.

Front Cell Neurosci. 2022 May 19;16:889939. doi: 10.3389/fncel.2022.889939. eCollection 2022.

Pathological Role of Natural Killer Cells in Parkinson's Disease: A Systematic Review

Zhang L, Zhang Y, Fan D.

Front Aging Neurosci. 2022 May 18;14:890816. doi: 10.3389/fnagi.2022.890816. eCollection 2022.

Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification

Grotemeyer A, McFleder RL, Wu J, Wischhusen J, Ip CW.

Front Immunol. 2022 May 18;13:878771. doi: 10.3389/fimmu.2022.878771. eCollection 2022.

α-Synuclein in the Synaptic Vesicle Liquid Phase: Active Player or Passive Bystander?

Brodin L, Milovanovic D, Rizzoli SO, Shupliakov O.

Front Mol Biosci. 2022 May 18;9:891508. doi: 10.3389/fmolb.2022.891508. eCollection 2022.

MALAT1 lncRNA and Parkinson's Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches

Abrishamdar M, Jalali MS, Rashno M.

Mol Neurobiol. 2022 Sep;59(9):5253-5262. doi: 10.1007/s12035-022-02899-z. Epub 2022 Jun 4.

Interventions for preventing falls in Parkinson's disease

Allen NE, Canning CG, Almeida LRS, Bloem BR, Keus SH, Löfgren N, Nieuwboer A, Verheyden GS, Yamato TP, Sherrington C.

Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD011574. doi: 10.1002/14651858.CD011574.pub2.

SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review

Imbalzano G, Ledda C, Artusi CA, Romagnolo A, Montanaro E, Rizzone MG, Lopiano L, Zibetti M.

Neurol Sci. 2022 Sep;43(9):5165-5168. doi: 10.1007/s10072-022-06182-w. Epub 2022 Jun 6.

Can Berberine Serve as a New Therapy for Parkinson's Disease?

Dadgostar E, Moghanlou M, Parvaresh M, Mohammadi S, Khandan M, Aschner M, Mirzaei H, Tamtaji OR.

Neurotox Res. 2022 Aug;40(4):1096-1102. doi: 10.1007/s12640-022-00526-2. Epub 2022 Jun 6.

The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies

Amin R, Quispe C, Docea AO, Ydyrys A, Kulbayeva M, Durna Daştan S, Calina D, Sharifi-Rad J.

Neurochem Int. 2022 Sep;158:105376. doi: 10.1016/j.neuint.2022.105376. Epub 2022 Jun 3.

Induced pluripotent stem cells: a tool for modeling Parkinson's disease

Bose A, Petsko GA, Studer L.

Trends Neurosci. 2022 Aug;45(8):608-620. doi: 10.1016/j.tins.2022.05.001. Epub 2022 Jun 3.

The role of Toll-like receptors and neuroinflammation in Parkinson's disease

Heidari A, Yazdanpanah N, Rezaei N.

J Neuroinflammation. 2022 Jun 6;19(1):135. doi: 10.1186/s12974-022-02496-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias